Cancer Research The Future of Cancer Research: Science and Patient Impact Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rofstad, E. K.
Right arrow Articles by Halsør, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rofstad, E. K.
Right arrow Articles by Halsør, E. F.
[Cancer Research 60, 4932-4938, September 1, 2000]
© 2000 American Association for Cancer Research

Tumor Biology

Vascular Endothelial Growth Factor, Interleukin 8, Platelet-derived Endothelial Cell Growth Factor, and Basic Fibroblast Growth Factor Promote Angiogenesis and Metastasis in Human Melanoma Xenografts1

Einar K. Rofstad2 and Ellen F. Halsør

Department of Biophysics, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo, Norway

Angiogenesis is a significant prognostic factor in melanoma, but the angiogenic factors controlling the neovascularization are not well defined. The purpose of this study was to investigate whether the angiogenesis and metastasis of melanoma are promoted by vascular endothelial growth factor (VEGF), interleukin 8 (IL-8), platelet-derived endothelial cell growth factor (PD-ECGF), and/or basic fibroblast growth factor (bFGF). Cells from human melanoma lines (A-07, D-12, R-18, and U-25) transplanted to BALB/c nu/nu mice were used as tumor models. Expression of angiogenic factors was studied by ELISA, Western blotting, and immunohistochemistry. Angiogenesis was assessed by using an intradermal angiogenesis assay. Lung colonization and spontaneous lung metastasis were determined after i.v. and intradermal inoculation of tumor cells, respectively. The specific roles of VEGF, IL-8, PD-ECGF, and bFGF in tumor angiogenesis, lung colonization, and spontaneous metastasis were assessed in mice treated with neutralizing antibody. The melanoma lines expressed multiple angiogenic factors, and each line showed a unique expression pattern. Multiple angiogenic factors promoted angiogenesis in the most angiogenic melanoma lines, whereas angiogenesis in the least angiogenic melanoma lines was possibly promoted solely by VEGF. Tumor growth, lung colonization, and spontaneous metastasis were controlled by the rate of angiogenesis and hence by the angiogenic factors promoting the angiogenesis. Lung colonization and spontaneous metastasis in A-07 were inhibited by treatment with neutralizing antibody against VEGF, IL-8, PD-ECGF, or bFGF. Each of these angiogenic factors may promote metastasis in melanoma, because inhibition of one of them could not be compensated for by the others. Our observations suggest that efficient antiangiogenic treatment of melanoma may require identification and blocking of common functional features of several angiogenic factors.




This article has been cited by other articles:


Home page
 Mol. Biol. CellHome page
M. L. Petreaca, M. Yao, Y. Liu, K. DeFea, and M. Martins-Green
Transactivation of Vascular Endothelial Growth Factor Receptor-2 by Interleukin-8 (IL-8/CXCL8) Is Required for IL-8/CXCL8-induced Endothelial Permeability
Mol. Biol. Cell, December 1, 2007; 18(12): 5014 - 5023.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. F. Gajewski
Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment
Clin. Cancer Res., September 15, 2007; 13(18): 5256 - 5261.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
C. Guruvayoorappan and G. Kuttan
{beta}-Carotene Inhibits Tumor-Specific Angiogenesis by Altering the Cytokine Profile and Inhibits the Nuclear Translocation of Transcription Factors in B16F-10 Melanoma Cells
Integr Cancer Ther, September 1, 2007; 6(3): 258 - 270.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
L. Zhang and R. P. Hill
Hypoxia Enhances Metastatic Efficiency in HT1080 Fibrosarcoma Cells by Increasing Cell Survival in Lungs, Not Cell Adhesion and Invasion
Cancer Res., August 15, 2007; 67(16): 7789 - 7797.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. K. Rofstad, K. Galappathi, B. Mathiesen, and E.-B. M. Ruud
Fluctuating and Diffusion-Limited Hypoxia in Hypoxia-Induced Metastasis
Clin. Cancer Res., April 1, 2007; 13(7): 1971 - 1978.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. K. Rofstad, B. Mathiesen, K. Kindem, and K. Galappathi
Acidic Extracellular pH Promotes Experimental Metastasis of Human Melanoma Cells in Athymic Nude Mice.
Cancer Res., July 1, 2006; 66(13): 6699 - 6707.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Su, Q. Zheng, M. M. Vaughan, Y. Bu, and I. H. Gelman
SSeCKS Metastasis-Suppressing Activity in MatLyLu Prostate Cancer Cells Correlates with Vascular Endothelial Growth Factor Inhibition
Cancer Res., June 1, 2006; 66(11): 5599 - 5607.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. A. Sosman and I. Puzanov
Molecular targets in melanoma from angiogenesis to apoptosis.
Clin. Cancer Res., April 1, 2006; 12(7): 2376s - 2383s.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Galie, C. Sorrentino, M. Montani, L. Micossi, E. Di Carlo, T. D'Antuono, L. Calderan, P. Marzola, D. Benati, F. Merigo, et al.
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells
Carcinogenesis, November 1, 2005; 26(11): 1868 - 1878.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Furuya, H. Kato, N. Nishimura, I. Ishiwata, H. Ikeda, R. Ito, T. Yoshiki, and H. Ishikura
Down-regulation of CD9 in Human Ovarian Carcinoma Cell Might Contribute to Peritoneal Dissemination: Morphologic Alteration and Reduced Expression of {beta}1 Integrin Subsets
Cancer Res., April 1, 2005; 65(7): 2617 - 2625.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. K. Rofstad, B. Mathiesen, K. Henriksen, K. Kindem, and K. Galappathi
The Tumor Bed Effect: Increased Metastatic Dissemination from Hypoxia-Induced Up-regulation of Metastasis-Promoting Gene Products
Cancer Res., March 15, 2005; 65(6): 2387 - 2396.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Panopoulou, C. Murphy, H. Rasmussen, E. Bagli, E. K. Rofstad, and T. Fotsis
Activin A Suppresses Neuroblastoma Xenograft Tumor Growth via Antimitotic and Antiangiogenic Mechanisms
Cancer Res., March 1, 2005; 65(5): 1877 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Rusnati, M. Camozzi, E. Moroni, B. Bottazzi, G. Peri, S. Indraccolo, A. Amadori, A. Mantovani, and M. Presta
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis
Blood, July 1, 2004; 104(1): 92 - 99.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Rousseau, F. Larrieu-Lahargue, S. Javerzat, F. Guilhem-Ducleon, F. Beermann, and A. Bikfalvi
The tyrp1-Tag/tyrp1-FGFR1-DN Bigenic Mouse: A Model for Selective Inhibition of Tumor Development, Angiogenesis, and Invasion into the Neural Tissue by Blockade of Fibroblast Growth Factor Receptor Activity
Cancer Res., April 1, 2004; 64(7): 2490 - 2495.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Abe, T. Shimizu, S.-i. Yamagishi, A. Shibaki, S. Amano, Y. Inagaki, H. Watanabe, H. Sugawara, H. Nakamura, M. Takeuchi, et al.
Overexpression of Pigment Epithelium-Derived Factor Decreases Angiogenesis and Inhibits the Growth of Human Malignant Melanoma Cells in Vivo
Am. J. Pathol., April 1, 2004; 164(4): 1225 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Takeuchi, A. Fujimoto, M. Tanaka, T. Yamano, E. Hsueh, and D. S. B. Hoon
CCL21 Chemokine Regulates Chemokine Receptor CCR7 Bearing Malignant Melanoma Cells
Clin. Cancer Res., April 1, 2004; 10(7): 2351 - 2358.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Goi, M. Fujioka, Y. Satoh, S. Tabata, K. Koneri, H. Nagano, Y. Hirono, K. Katayama, K. Hirose, and A. Yamaguchi
Angiogenesis and Tumor Proliferation/Metastasis of Human Colorectal Cancer Cell Line SW620 Transfected with Endocrine Glands-Derived-Vascular Endothelial Growth Factor, As a New Angiogenic Factor
Cancer Res., March 15, 2004; 64(6): 1906 - 1910.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. K. Rofstad, B. Mathiesen, and K. Galappathi
Increased Metastatic Dissemination in Human Melanoma Xenografts after Subcurative Radiation Treatment: Radiation-induced Increase in Fraction of Hypoxic Cells and Hypoxia-induced Up-Regulation of Urokinase-Type Plasminogen Activator Receptor
Cancer Res., January 1, 2004; 64(1): 13 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. P. Lefter, M. Sunamura, T. Furukawa, K. Takeda, N. Kotobuki, M. Oshimura, S. Matsuno, and A. Horii
Inserting Chromosome 18 into Pancreatic Cancer Cells Switches Them to a Dormant Metastatic Phenotype
Clin. Cancer Res., October 15, 2003; 9(13): 5044 - 5052.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Patel, L. Sun, D. Moshinsky, H. Chen, K. M. Leahy, P. Le, K. G. Moss, X. Wang, A. Rice, D. Tam, et al.
A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular Permeability
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 838 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. C. Lev, M. Ruiz, L. Mills, E. C. McGary, J. E. Price, and M. Bar-Eli
Dacarbazine Causes Transcriptional Up-Regulation of Interleukin 8 and Vascular Endothelial Growth Factor in Melanoma Cells: A Possible Escape Mechanism from Chemotherapy
Mol. Cancer Ther., August 1, 2003; 2(8): 753 - 763.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. K. Rofstad, K. Henriksen, K. Galappathi, and B. Mathiesen
Antiangiogenic Treatment with Thrombospondin-1 Enhances Primary Tumor Radiation Response and Prevents Growth of Dormant Pulmonary Micrometastases after Curative Radiation Therapy in Human Melanoma Xenografts
Cancer Res., July 15, 2003; 63(14): 4055 - 4061.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Feoktistov, S. Ryzhov, A. E. Goldstein, and I. Biaggioni
Mast Cell-Mediated Stimulation of Angiogenesis: Cooperative Interaction Between A2B and A3 Adenosine Receptors
Circ. Res., March 21, 2003; 92(5): 485 - 492.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
O. Straume, D. G. Jackson, and L. A. Akslen
Independent Prognostic Impact of Lymphatic Vessel Density and Presence of Low-Grade Lymphangiogenesis in Cutaneous Melanoma
Clin. Cancer Res., January 1, 2003; 9(1): 250 - 256.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Y. Mishima, Y. Matsumoto-Mishima, Y. Terui, M. Katsuyama, M. Yamada, M. Mori, Y. Ishizaka, K. Ikeda, J.-i. Watanabe, N. Mizunuma, et al.
Leukemic Cell-Surface CD13/Aminopeptidase N and Resistance to Apoptosis Mediated by Endothelial Cells
J Natl Cancer Inst, July 3, 2002; 94(13): 1020 - 1028.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Feoktistov, A. E. Goldstein, S. Ryzhov, D. Zeng, L. Belardinelli, T. Voyno-Yasenetskaya, and I. Biaggioni
Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation
Circ. Res., March 22, 2002; 90(5): 531 - 538.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. De Marchis, D. Ribatti, C. Giampietri, A. Lentini, D. Faraone, M. Scoccianti, M. C. Capogrossi, and A. Facchiano
Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor
Blood, March 15, 2002; 99(6): 2045 - 2053.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. K. Rofstad, H. Rasmussen, K. Galappathi, B. Mathiesen, K. Nilsen, and B. A. Graff
Hypoxia Promotes Lymph Node Metastasis in Human Melanoma Xenografts by Up-Regulating the Urokinase-Type Plasminogen Activator Receptor
Cancer Res., March 1, 2002; 62(6): 1847 - 1853.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma Progression
Am. J. Pathol., March 1, 2002; 160(3): 1009 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
K. Satyamoorthy, G. Li, B. Vaidya, J. Kalabis, and M. Herlyn
Insulin-like Growth Factor-I-induced Migration of Melanoma Cells Is Mediated by Interleukin-8 Induction
Cell Growth Differ., February 1, 2002; 13(2): 87 - 93.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Berking, R. Takemoto, H. Schaider, L. Showe, K. Satyamoorthy, P. Robbins, and M. Herlyn
Transforming Growth Factor-{beta}1 Increases Survival of Human Melanoma through Stroma Remodeling
Cancer Res., November 1, 2001; 61(22): 8306 - 8316.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas
Am. J. Pathol., July 1, 2001; 159(1): 223 - 235.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Feoktistov, A. E. Goldstein, S. Ryzhov, D. Zeng, L. Belardinelli, T. Voyno-Yasenetskaya, and I. Biaggioni
Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation
Circ. Res., March 22, 2002; 90(5): 531 - 538.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.